222 related articles for article (PubMed ID: 33681365)
1. Profiles of Innate Immune Cell Infiltration and Related Core Genes in Psoriasis.
Gong X; Wang W
Biomed Res Int; 2021; 2021():6656622. PubMed ID: 33681365
[TBL] [Abstract][Full Text] [Related]
2. Immune Cell Infiltration Analysis Demonstrates Excessive Mast Cell Activation in Psoriasis.
Zhang Y; Shi Y; Lin J; Li X; Yang B; Zhou J
Front Immunol; 2021; 12():773280. PubMed ID: 34887864
[TBL] [Abstract][Full Text] [Related]
3. Rorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice.
Pantelyushin S; Haak S; Ingold B; Kulig P; Heppner FL; Navarini AA; Becher B
J Clin Invest; 2012 Jun; 122(6):2252-6. PubMed ID: 22546855
[TBL] [Abstract][Full Text] [Related]
4. Immune functions and recruitment of plasmacytoid dendritic cells in psoriasis.
Albanesi C; Scarponi C; Bosisio D; Sozzani S; Girolomoni G
Autoimmunity; 2010 Apr; 43(3):215-9. PubMed ID: 20166874
[TBL] [Abstract][Full Text] [Related]
5. Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells.
Nadeem A; Ahmad SF; Al-Harbi NO; El-Sherbeeny AM; Alasmari AF; Alanazi WA; Alasmari F; Ibrahim KE; Al-Harbi MM; Bakheet SA; Attia SM
Int Immunopharmacol; 2020 Mar; 80():106215. PubMed ID: 31982823
[TBL] [Abstract][Full Text] [Related]
6. The new insight into the role of antimicrobial proteins-alarmins in the immunopathogenesis of psoriasis.
Batycka-Baran A; Maj J; Wolf R; Szepietowski JC
J Immunol Res; 2014; 2014():628289. PubMed ID: 24901012
[TBL] [Abstract][Full Text] [Related]
7. Signs of innate immune activation and premature immunosenescence in psoriasis patients.
Šahmatova L; Sügis E; Šunina M; Hermann H; Prans E; Pihlap M; Abram K; Rebane A; Peterson H; Peterson P; Kingo K; Kisand K
Sci Rep; 2017 Aug; 7(1):7553. PubMed ID: 28790368
[TBL] [Abstract][Full Text] [Related]
8. Single-cell RNA-Seq reveals the transcriptional landscape and heterogeneity of skin macrophages in Vsir
Qie C; Jiang J; Liu W; Hu X; Chen W; Xie X; Liu J
Theranostics; 2020; 10(23):10483-10497. PubMed ID: 32929361
[No Abstract] [Full Text] [Related]
9. Targeting L-type amino acid transporter 1 in innate and adaptive T cells efficiently controls skin inflammation.
Cibrian D; Castillo-González R; Fernández-Gallego N; de la Fuente H; Jorge I; Saiz ML; Punzón C; Ramírez-Huesca M; Vicente-Manzanares M; Fresno M; Daudén E; Fraga-Fernandez J; Vazquez J; Aragonés J; Sánchez-Madrid F
J Allergy Clin Immunol; 2020 Jan; 145(1):199-214.e11. PubMed ID: 31605740
[TBL] [Abstract][Full Text] [Related]
10. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes.
Nomura I; Goleva E; Howell MD; Hamid QA; Ong PY; Hall CF; Darst MA; Gao B; Boguniewicz M; Travers JB; Leung DY
J Immunol; 2003 Sep; 171(6):3262-9. PubMed ID: 12960356
[TBL] [Abstract][Full Text] [Related]
11. Genome wide transcriptome analysis of dendritic cells identifies genes with altered expression in psoriasis.
Filkor K; Hegedűs Z; Szász A; Tubak V; Kemény L; Kondorosi É; Nagy I
PLoS One; 2013; 8(9):e73435. PubMed ID: 24039940
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of IL-12p70 and IL-23 by multiple dendritic cell and macrophage subsets in plaque psoriasis.
Yawalkar N; Tscharner GG; Hunger RE; Hassan AS
J Dermatol Sci; 2009 May; 54(2):99-105. PubMed ID: 19264456
[TBL] [Abstract][Full Text] [Related]
13. IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice.
Van Belle AB; de Heusch M; Lemaire MM; Hendrickx E; Warnier G; Dunussi-Joannopoulos K; Fouser LA; Renauld JC; Dumoutier L
J Immunol; 2012 Jan; 188(1):462-9. PubMed ID: 22131335
[TBL] [Abstract][Full Text] [Related]
14. Cellular sources of IL-17 in psoriasis: a paradigm shift?
Keijsers RR; Joosten I; van Erp PE; Koenen HJ; van de Kerkhof PC
Exp Dermatol; 2014 Nov; 23(11):799-803. PubMed ID: 25039885
[TBL] [Abstract][Full Text] [Related]
15. Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis.
Mashiko S; Bouguermouh S; Rubio M; Baba N; Bissonnette R; Sarfati M
J Allergy Clin Immunol; 2015 Aug; 136(2):351-9.e1. PubMed ID: 25792465
[TBL] [Abstract][Full Text] [Related]
16. The immunopathogenesis of psoriasis.
Kim J; Krueger JG
Dermatol Clin; 2015 Jan; 33(1):13-23. PubMed ID: 25412780
[TBL] [Abstract][Full Text] [Related]
17. Identification of cellular pathways of "type 1," Th17 T cells, and TNF- and inducible nitric oxide synthase-producing dendritic cells in autoimmune inflammation through pharmacogenomic study of cyclosporine A in psoriasis.
Haider AS; Lowes MA; Suárez-Fariñas M; Zaba LC; Cardinale I; Khatcherian A; Novitskaya I; Wittkowski KM; Krueger JG
J Immunol; 2008 Feb; 180(3):1913-20. PubMed ID: 18209089
[TBL] [Abstract][Full Text] [Related]
18. Aldara-induced psoriasis-like skin inflammation: isolation and characterization of cutaneous dendritic cells and innate lymphocytes.
Wohn CT; Pantelyushin S; Ober-Blöbaum JL; Clausen BE
Methods Mol Biol; 2014; 1193():171-85. PubMed ID: 25151006
[TBL] [Abstract][Full Text] [Related]
19. Dynamics and Transcriptomics of Skin Dendritic Cells and Macrophages in an Imiquimod-Induced, Biphasic Mouse Model of Psoriasis.
Terhorst D; Chelbi R; Wohn C; Malosse C; Tamoutounour S; Jorquera A; Bajenoff M; Dalod M; Malissen B; Henri S
J Immunol; 2015 Nov; 195(10):4953-61. PubMed ID: 26466959
[TBL] [Abstract][Full Text] [Related]
20. Psoriasis: dysregulation of innate immunity.
Bos JD; de Rie MA; Teunissen MB; Piskin G
Br J Dermatol; 2005 Jun; 152(6):1098-107. PubMed ID: 15948970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
